Avadel Pharmaceuticals Stock Forecast - Period Momentum Indicator
| AVDL Stock | USD 11.22 0.44 3.77% |
Avadel Stock Forecast is based on your current time horizon. Although Avadel Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Avadel Pharmaceuticals' systematic risk associated with finding meaningful patterns of Avadel Pharmaceuticals fundamentals over time.
Avadel |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.48) | (0.44) |
| Check Avadel Pharmaceuticals Volatility | Backtest Avadel Pharmaceuticals | Information Ratio |
Avadel Pharmaceuticals Trading Date Momentum
| On November 26 2024 Avadel Pharmaceuticals PLC was traded for 11.22 at the closing time. The top price for the day was 11.82 and the lowest listed price was 11.20 . There was no trading activity during the period 0.0. Lack of trading volume on November 26, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.28% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Avadel Pharmaceuticals to competition |
Other Forecasting Options for Avadel Pharmaceuticals
For every potential investor in Avadel, whether a beginner or expert, Avadel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Avadel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Avadel. Basic forecasting techniques help filter out the noise by identifying Avadel Pharmaceuticals' price trends.Avadel Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avadel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Avadel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Avadel Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Avadel Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Avadel Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Avadel Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Avadel Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Avadel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avadel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Avadel Pharmaceuticals stock market strength indicators, traders can identify Avadel Pharmaceuticals PLC entry and exit signals to maximize returns.
Avadel Pharmaceuticals Risk Indicators
The analysis of Avadel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Avadel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting avadel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.43 | |||
| Standard Deviation | 4.32 | |||
| Variance | 18.68 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Avadel Pharmaceuticals to cross-verify your projections. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.